-
Nifedipine (BAY-a-1040) Research Workflows
2026-08-28
Nifedipine (BAY-a-1040) enables controlled calcium influx inhibition across live-cell, renal, hepatic, and fungal assays. This practical guide connects concentration-response design with iron metabolism modulation and the PXR-regulated metabolic adaptation described in a recent rat liver study, while separating established evidence from exploratory applications.
-
Hydroxytyrosol Workflows for Cardiovascular Research
2026-08-28
Build reproducible oxidative-stress, macrophage-inflammation, and cholesterol-efflux assays with Hydroxytyrosol. This practical guide converts concentration-dependent olive-oil polyphenol findings into bench-ready workflows, controls, and troubleshooting decisions.
-
Rapid Microwave Heating Preserves Lactoferrin Function
2026-08-27
The reference study shows that rapid microwave heating preserves lactoferrin more effectively than conventional thermal treatment primarily because it shortens exposure to the protein’s denaturation range, rather than because of a unique microwave dielectric effect. Structural retention was associated with stronger iron-binding, antioxidant, anti-inflammatory, and anti-apoptotic activity, offering a mechanistic basis for optimizing dairy pasteurization.
-
AO/PI Staining Solution for Diabetic Nephropathy
2026-08-27
AO/PI Staining Solution enables rapid live/dead cell discrimination in diabetic nephropathy and cytotoxicity workflows, including samples where debris or red blood cells can compromise trypan blue counts. Its two-color readout supports more defensible fluorescence-based cell counting before mechanistic assays such as apoptosis, inflammation, and pathway analysis.
-
Cy5 Hydrazide: Carbonyl Labeling in FAST Nanoparticles
2026-08-26
Cy5 hydrazide enables far-red carbonyl-reactive fluorescent dye labeling of oxidized proteins, glycoproteins, oligonucleotides, and nanoparticle-associated biomolecules. This article provides an assay-interpretation framework that distinguishes covalent carbonyl signals from nonspecific nanoparticle fluorescence.
-
A 83-01 ALK Inhibitor for Organoid Research
2026-08-26
A 83-01 is a potent ALK-5 inhibitor for dissecting TGF-β/Smad signaling, EMT, and growth-control phenotypes. Its use as a pathway perturbation in hiPSC-derived intestinal organoid workflows can add mechanistic resolution to pharmacokinetic and epithelial-barrier studies, provided concentration, vehicle, and organoid context are carefully controlled.
-
NSC 87877 for SHP2 Neuroinflammation Studies
2026-08-25
NSC 87877 is a selective Shp2 inhibitor for connecting phosphatase activity with EGF–Ras–Erk signaling, microglial inflammation, leukemia-cell responses, and pain biology. This workflow-oriented guide shows how to use it as a mechanistic probe while controlling for Shp1 activity, compound handling, cytotoxicity, and cross-model interpretation.
-
PAD4-IN-2 TFA: Targeting the PAD4–NET Axis
2026-08-25
PAD4-IN-2 TFA, also known as Compound 5i TFA, illustrates how tumor-directed chemistry can convert PAD4 inhibition from a broadly distributed mechanism into a more selective strategy for studying tumor growth, metastasis, and neutrophil biology. This thought-leadership article connects the PAD4–H3cit–NET pathway with experimental design, translational decision-making, and practical use of the compound.
-
Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain
2026-08-24
A 2024 study identifies a causal Kir4.1–ROS–p38 MAPK–Panx3 axis in trigeminal ganglion satellite glial cells during orofacial neuropathic pain. Its combination of injury modeling, cell-specific genetic manipulation, and pathway rescue experiments provides a framework for separating glial ion-channel regulation from downstream pain signaling.
-
Latrunculin B: Mechanism and Study Design
2026-08-24
Latrunculin B is a cell-permeable actin polymerization inhibitor that binds monomeric G-actin and transiently limits filament assembly. This latrunculin b inhibitor is useful for short-duration actin cytoskeleton disruption, but a 2018 reovirus study found that it did not block viral entry under the tested CIK-cell conditions.
-
Nanoparticle Uptake in Human Corneal Epithelial Cells
2026-08-23
The 2024 ACS Biomaterials Science & Engineering study systematically examined how PLGA nanoparticle size and surface chemistry affect uptake by human corneal epithelial cells. Its controlled particle panel and inhibitor-based experiments identified energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as the dominant mechanisms under the tested conditions.
-
ZK53: A Decision Framework for ClpP Research
2026-08-22
ZK53 is a selective human mitochondrial serine protease ClpP activator that connects mitochondrial proteostasis to cancer-cell vulnerability. This evidence-based guide explains how to interpret its biochemical, cellular, and in vivo data without conflating assay potency with biological mechanism.
-
EdU Imaging Kits (Cy3): Mechanistic Assay Guide
2026-08-22
EdU Imaging Kits (Cy3) transform S-phase DNA synthesis into a sensitive fluorescence readout. This guide explains how to apply a 5-ethynyl-2'-deoxyuridine imaging kit to mechanistic ferroptosis research while avoiding misleading interpretations of reduced proliferation.
-
SIRT1/2 Inhibitor IV (cambinol) Guide
2026-08-21
This scenario-based guide explains how SIRT1/2 Inhibitor IV (cambinol), SKU B6063, can improve interpretation of viability, proliferation, acetylation, and hypoxia-response experiments. It connects biochemical potency, cell-based controls, handling practices, and vendor-selection criteria to current SIRT1 research while clearly separating established evidence from testable hypotheses.
-
NAD+ Strategy for Translational RGC Research
2026-08-20
A mechanistic and strategic guide to positioning Nicotinamide Riboside Chloride (NIAGEN) within reproducible iPSC-derived retinal ganglion cell workflows, while distinguishing product-supported biology from exploratory translational hypotheses.